首页 › 基金 › Velan Capital Investment Management LP › VRCA

Velan Capital Investment Management LP 对 VRCA 的持仓历史

VERRICA PHARMACEUTICALS INC · 医疗保健

Velan Capital Investment Management LP 在 Q2 2026 的 13F 申报中披露持有 VRCA(VERRICA PHARMACEUTICALS INC)471,559 股,市值约 US$2.9M,约占其申报组合的 1.85%,在其申报持仓中市值排名第 14 位。 Velan Capital Investment Management LP 最近 3 个申报季度中有 3 个季度披露了 VRCA 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)471.56K 股
申报持仓市值$2.89M
组合权重1.85%
首次申报Q4 2025
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Velan Capital Investment Management LP 对 VRCA 的持仓演变

Velan Capital Investment Management LP 于 Q4 2025 首次披露 VRCA 持仓:471,559 股(约 US$3.9M)。 在 3 次申报中,Velan Capital Investment Management LP 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 471,559 股、市值约 US$2.9M。

逐季持仓明细

季度股数金额变化
Q4 2025 471.56K $3.92M 新进
Q1 2026 471.56K $2.49M 持有
Q2 2026 471.56K $2.89M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VRCA 与 13F 数据

VRCA(VERRICA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 VRCA,申报仓位最大的包括:Caligan Partners LP (US$5.7M), CANNELL CAPITAL LLC (US$4.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VRCA 的基金

查看 VRCA 的全部基金持有人 →

常见问题

How long has Velan Capital Investment Management LP held VRCA?

Velan Capital Investment Management LP has disclosed VRCA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Velan Capital Investment Management LP's current position in VRCA?

As of Q2 2026, Velan Capital Investment Management LP holds 471.56K shares of VRCA (VERRICA PHARMACEUTICALS INC), valued at $2.89M, representing 1.85% of its reported portfolio and ranking #14.

Has Velan Capital Investment Management LP been buying or selling VRCA?

In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP held unchanged its position in VRCA.

Which other funds hold VRCA?

Other major institutional holders of VRCA include Caligan Partners LP, CANNELL CAPITAL LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.